HIGHLIGHTED ARTICLES FROM ANNALS OF SURGICAL ONCOLOGY
Weekly Update
Plasma Exosome Gene Signature Differentiates Colon Cancer from Healthy Controls
March 9, 2023
Citation:
Vallejos, P.A., Gonda, A., Yu, J. et al. Plasma Exosome Gene Signature Differentiates Colon Cancer from Healthy Controls. Ann Surg Oncol (2023). https://doi.org/10.1245/s10434-023-13219-7
Synopsis: Current liquid biopsy options lack sensitivity in peritoneal carcinomatosis (PC). In this initial feasibility analysis, we have identified a plasma exosome-based gene signature of 445 genes from colon cancer patients, including those with PC, that is distinct from healthy controls.
Preoperative Partial Breast Irradiation in Patients with Low-Risk Breast Cancer: A Systematic Review of Literature
March 9, 2023
Citation:
Civil, Y.A., Jonker, L.W., Groot Koerkamp, M.P.M. et al. Preoperative Partial Breast Irradiation in Patients with Low-Risk Breast Cancer: A Systematic Review of Literature. Ann Surg Oncol (2023). https://doi.org/10.1245/s10434-023-13233-9
Synopsis: This systematic review shows that pre-operative partial breast irradiation is a feasible treatment option in patients with low-risk breast cancer. Pathologic complete response was reported in almost half of the patients with acceptable toxicity, good oncological and cosmetic outcomes.
Listen to the ASO's new podcast, Speaking of SurgOnc®
Speaking of SurgOnc® is a podcast brought to you by the Annals of Surgical Oncology (ASO) and the Society of Surgical Oncology (SSO).
The series is hosted by ASO Deputy Editor Dr. Frederick L. (Rick) Greene, who will expand upon ideas from articles published in the Annals. Once a month, Dr. Greene will interview authors and leading experts in surgical oncology.
Listen to the podcast here.
ASO is the journal of choice of surgical oncologists and cancer multidisciplinary teams worldwide regarding surgical oncology research and education, and benefits surgeons, oncologists, hematologists, radiologists, general practitioners, pathologists, researchers, academicians, and other clinical professionals interested in all aspects of the surgical treatment of cancer. ASO strives to improve the practice environment in which high-quality surgical oncology care is delivered, to enhance the quality of life and survival of the surgical patient with cancer.
Join the conversation! Follow the journal on Twitter and Facebook. Help to expand the reach of the journal to support the research and practice needs of surgical oncologists and their patients.
